文献速递功能神经外科神经重症

立体定向脑电图引导下射频热凝毁损 eloquent 运动皮层癫痫灶的可行性、安全性与疗效

Stereoelectroencephalography-Guided Radiofrequency Thermocoagulation of Epileptic Foci in the Eloquent Motor Cortex: Feasibility, Safety, and Efficacy.
PubMed 文献 · World Neurosurg · 2022-05-07

该回顾性研究纳入2017至2021年15例药物难治性局灶性癫痫患者,癫痫灶位于 eloquent 运动区,均以立体定向脑电图引导下射频热凝毁损(SEEG-guided RFTC)作为首选治疗。12例(80%)患者发作频率下降≥75%,其中9例(60%)获得长期无发作;9例出现神经功能缺损,8例为暂时性。作者认为该术式似乎安全有效,但需更大样本前瞻性研究验证。

要点

  • 15例 eloquent 运动区药物难治性癫痫患者以 SEEG 引导 RFTC 为首选,12例(80%)发作频率下降≥75%。
  • 9例(60%)获得长期无发作,无发作期10-29个月,平均21.3个月。
  • 9例术后即刻出现神经功能缺损,8例为暂时性(3天至3周),1例为持续性。

核心结论

  • SEEG 引导 RFTC 治疗 eloquent 运动区癫痫灶似乎安全有效,可能成为不适合手术切除的药物难治性癫痫的首选方案,尤其适用于靠近或位于中央区皮层的极局灶性癫痫灶。
  • 作者指出需要更大样本的前瞻性研究来验证其结论。

研究设计与样本

  • 回顾性分析2017至2021年15例 eloquent 运动区药物难治性局灶性癫痫患者的病历与手术资料,所有患者均以 SEEG 引导 RFTC 作为首选治疗。

主要发现

  • 患者为12例男性和3例女性,RFTC 时平均年龄25±8.5岁(范围14-48岁),SEEG 前平均癫痫病程9.5±7.0年(范围2-26年),平均随访22.1个月(范围8-41个月)。
  • MRI 表现:2例阴性,10例疑诊局灶性皮质发育不良,2例中央区带状灰质异位,1例皮层发育畸形。
  • RFTC 部位:中央前回原发区(M1)7例(46.7%),中央旁小叶4例(26.7%),辅助运动区2例(13.3%),运动前区2例(13.3%)。
  • 15例中12例(80%)发作频率下降≥75%,其中9例(60%)获得长期无发作(10-29个月,平均21.3个月);3例(20%)未从 RFTC 获益。
  • 9例术后即刻出现神经功能缺损,其中8例为暂时性(3天至3周),1例为持续性。

临床怎么用

  • 原文结论认为 SEEG 引导 RFTC 对于不适合手术切除的药物难治性癫痫可能是首选方案,尤其适用于靠近或位于中央区皮层的极局灶性癫痫灶,但需更大样本前瞻性研究验证。

局限性

  • 原文指出需要更大样本的前瞻性研究来验证其结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess safety and long-term outcome of stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation (RFTC) of epileptic foci in eloquent motor areas. METHODS: We retrospectively reviewed medical charts and surgical features of 15 patients with drug-resistant focal epilepsy in eloquent motor areas treated between 2017 and 2021. All patients underwent SEEG-guided RFTC as the first option. General characteristics, SEEG findings, morbidity, and seizure outcome after RFTC were analyzed to extract the potential value of SEEG-guided RFTC for epileptic foci in eloquent motor areas. RESULTS: There were 12 male and 3 female patients. Mean age at RFTC was 25 ± 8.5 years (range, 14-48 years), and mean duration of epilepsy before SEEG was 9.5 ± 7.0 years (range, 2-26 years). Mean follow-up period was 22.1 months (range, 8-41 months). Magnetic resonance imaging findings were negative in 2 cases, suspected focal cortical dysplasia in 10 cases, central region band heterotopias in 2 cases, and malformations of cortical development in 1 case. RFTC sites included primary precentral area (M1) (7, 46.7%), paracentral lobule (4, 26.7%), supplemental motor area (2, 13.3%), and premotor area (2, 13.3%). Of 15 patients, 12 (80%) experienced a ≥75% decrease in seizure frequency, of whom 9 (60%) experienced a long-term seizure-free period (10-29 months, mean 21.3 months). Three (20%) patients did not benefit from RFTC. Nine patients had neurological deficits immediately after RFTC (transient in 8 patients [3 days to 3 weeks] and prolonged in 1 patient). CONCLUSIONS: SEEG-guided RFTC for epileptic foci in eloquent motor areas seems to be a safe and effective procedure. It could be the first option for drug-resistant epilepsy that is not amenable to surgical resection, especially for extremally focused epileptic foci in the cortex close to or inside the central region. Larger series and prospective studies are necessary to validate our conclusions.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Xu Y, Wang H, Zhao Y, et al. Stereoelectroencephalography-Guided Radiofrequency Thermocoagulation of Epileptic Foci in the Eloquent Motor Cortex: Feasibility, Safety, and Efficacy. World Neurosurg. 2022. PMID: 35537694. doi:10.1016/j.wneu.2022.04.133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。